HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$20.26
Day range
$19.76 - $21.75
Year range
$18.20 - $31.13
Market cap
709.07M USD
Avg Volume
161.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 29.45M | — |
Net income | -28.62M | — |
Net profit margin | — | — |
Earnings per share | -1.46 | — |
EBITDA | -29.45M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 410.88M | — |
Total assets | 414.09M | — |
Total liabilities | 18.88M | — |
Total equity | 395.21M | — |
Shares outstanding | 35.00M | — |
Price to book | 2.09 | — |
Return on assets | -33.91% | — |
Return on capital | -37.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -28.62M | — |
Cash from operations | -27.82M | — |
Cash from investing | -171.00K | — |
Cash from financing | 423.74M | — |
Net change in cash | 395.75M | — |
Free cash flow | -11.66M | — |
About
Headquarters
Website
Employees
27
